Quality of life assessment in vitiligo patients: a cross-sectional study
Anais Brasileiros de Dermatologia · 2026-03 · 101 (2) · 501305
DOI: 10.1016/j.abd.2026.501305 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-03. Verfasst von Natália Maria Neves Simões und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, Universidade de São Paulo, São Paulo, Brazil. Electronic address: nataliasimoe…. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, Universidade de São Paulo, São Paulo, Brazil. Electronic address: nataliasimoes.dermatologia@gmail.com.
- Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil.
- Department of Pathology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil.
- Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, Universidade de São Paulo, São Paulo, Brazil.
Zitieren
APA
Simões, N. M. N., Franciscatti, G. C., Froes Junior, L. A. R., & Quaresma, M. V. (2026). Quality of life assessment in vitiligo patients: a cross-sectional study. Anais Brasileiros de Dermatologia, 101(2), 501305. https://doi.org/10.1016/j.abd.2026.501305
Vancouver
Simões NMN, Franciscatti GC, Froes Junior LAR, Quaresma MV. Quality of life assessment in vitiligo patients: a cross-sectional study. Anais Brasileiros de Dermatologia. 2026;101(2):501305. doi:10.1016/j.abd.2026.501305
BibTeX
@article{Simes2026,
author = {Simões, Natália Maria Neves and Franciscatti, Gabrielle Cassulo and Froes Junior, Luis Alberto Ribeiro and Quaresma, Maria Victória},
title = {Quality of life assessment in vitiligo patients: a cross-sectional study},
journal = {Anais Brasileiros de Dermatologia},
year = {2026},
volume = {101},
number = {2},
pages = {501305},
doi = {10.1016/j.abd.2026.501305}
}
EUVIMED